As of February 2019, over half of the 132 drugs in development for Alzheimer's disease were in the second clinical trial phase. This statistic depicts the amount of Alzheimer's drugs in development as of February 2019, by clinical trial phase.
Alzheimer's drugs in developmen as of February 2019, by clinical trial phase
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
BioSpace. (September 23, 2019). Alzheimer's drugs in developmen as of February 2019, by clinical trial phase [Graph]. In Statista. Retrieved August 25, 2024, from https://www.statista.com/statistics/1093301/alzheimers-drugs-in-development-by-trial-phase-us/
BioSpace. "Alzheimer's drugs in developmen as of February 2019, by clinical trial phase." Chart. September 23, 2019. Statista. Accessed August 25, 2024. https://www.statista.com/statistics/1093301/alzheimers-drugs-in-development-by-trial-phase-us/
BioSpace. (2019). Alzheimer's drugs in developmen as of February 2019, by clinical trial phase. Statista. Statista Inc.. Accessed: August 25, 2024. https://www.statista.com/statistics/1093301/alzheimers-drugs-in-development-by-trial-phase-us/
BioSpace. "Alzheimer's Drugs in Developmen as of February 2019, by Clinical Trial Phase." Statista, Statista Inc., 23 Sep 2019, https://www.statista.com/statistics/1093301/alzheimers-drugs-in-development-by-trial-phase-us/
BioSpace, Alzheimer's drugs in developmen as of February 2019, by clinical trial phase Statista, https://www.statista.com/statistics/1093301/alzheimers-drugs-in-development-by-trial-phase-us/ (last visited August 25, 2024)
Alzheimer's drugs in developmen as of February 2019, by clinical trial phase [Graph], BioSpace, September 23, 2019. [Online]. Available: https://www.statista.com/statistics/1093301/alzheimers-drugs-in-development-by-trial-phase-us/